Compass Point assumed coverage on shares of Trulieve Cannabis (OTCMKTS:TCNNF) in a report issued on Thursday, The Fly reports. The firm set a “hold” rating and a $9.00 price target on the stock. Compass Point’s price objective would indicate a potential downside of 2.54% from the company’s current price.
OTCMKTS:TCNNF traded down $0.21 during midday trading on Thursday, hitting $9.24. The company had a trading volume of 250,420 shares, compared to its average volume of 203,185. Trulieve Cannabis has a 52-week low of $6.68 and a 52-week high of $21.00. The stock’s fifty day moving average price is $9.04 and its 200-day moving average price is $11.37.
About Trulieve Cannabis
Trulieve Cannabis Corp. operates as a medical marijuana company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as directly to patients via home delivery. It produces approximately 150 stock keeping units, including nasal sprays, capsules, concentrates, syringes, cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridge.
Read More: What is an inverted yield curve?
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.